tradingkey.logo
tradingkey.logo
Suchen

Bionano Genomics Inc

BNGO
Zur Watchlist hinzufügen
1.150USD
-0.020-1.71%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
12.97MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Bionano Genomics Inc Unternehmen

Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).

Bionano Genomics Inc Informationen

BörsenkürzelBNGO
Name des UnternehmensBionano Genomics Inc
IPO-datumAug 01, 2018
CEOHolmlin (R. Erik)
Anzahl der mitarbeiter98
WertpapierartOrdinary Share
GeschäftsjahresendeAug 01
Addresse9540 Towne Centre Drive
StadtSAN DIEGO
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl92121
Telefon18588887600
Websitehttps://bionano.com/
BörsenkürzelBNGO
IPO-datumAug 01, 2018
CEOHolmlin (R. Erik)

Führungskräfte von Bionano Genomics Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
619.00
-4.36%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
254.00
-2.76%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
107.00
+84.11%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
Dr. Albert A. Luderer, Ph.D.
Dr. Albert A. Luderer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Kristiina Vuori, M.D., Ph.D.
Dr. Kristiina Vuori, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Yvonne Linney, Ph.D.
Dr. Yvonne Linney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Alka Chaubey, Ph.D.
Dr. Alka Chaubey, Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
619.00
-4.36%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
254.00
-2.76%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
107.00
+84.11%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Bionano Genomics Inc?

Die fünf größten Anteilseigner von Bionano Genomics Inc sind: Mr. Mark Oldakowski

Wie viele Institutionen halten Anteile an Bionano Genomics Inc (BNGO)?

Mit Stand vom 2026Q1 halten 109 Institutionen Anteile an Bionano Genomics Inc, mit einem Gesamtmarktwert von etwa 1.17M, was 10.52% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 32263.00 gestiegen.

Was ist die größte Einnahmequelle von Bionano Genomics Inc?

Am 2026Q1 erzielte das Geschäft mit Consumables für Bionano Genomics Inc den höchsten Umsatz in Höhe von 13.97M, was 49.00% des Gesamtumsatzes entspricht.